ABVC BioPharma, Inc. (ABVC) Operating margin 2018–2025
ABVC BioPharma, Inc. (ABVC) operating margin by fiscal year — reported operating income divided by reported revenue.
-2416.0%FY2025 · since FY2018: -40031.1% → -2416.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2416.0% | -1492.6 pp |
| FY2024 | -923.3% | +3515.9 pp |
| FY2023 | -4439.2% | -2880.7 pp |
| FY2022 | -1558.5% | +1731.5 pp |
| FY2021 | -3290.1% | -1529.2 pp |
| FY2020 | -1760.9% | -1268.0 pp |
| FY2019 | -492.9% | +39538.2 pp |
| FY2018 | -40031.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice